Multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: An NF Clinical Trials Consortium study Meeting Abstract
| Authors: | Plotkin, S.; Tonsgard, J.; Ullrich, N.; Allen, J.; Blakeley, J.; Rosser, T.; Campian, J.; Clapp, W.; Fisher, M.; Cutter, G.; Korf, B.; Packer, R.; Thomas, C.; Karjannis, M. |
| Abstract Title: | Multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: An NF Clinical Trials Consortium study |
| Meeting Title: | 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 19 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2017 Nov 16-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-11-01 |
| Start Page: | vi215 |
| Language: | English |
| ACCESSION: | WOS:000415152503231 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/nox168.868 |
| PMCID: | PMC5691935 |
| Notes: | Meeting Abstract: RARE-19 -- Matthias Karajannis's last name is misspelled on the original publication -- Joint Conference of 22nd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology / Conference of the Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on Therapeutic Delivery to the CNS -- NOV 15-19, 2017 -- San Francisco, CA -- Source: Wos |
